Insider Transactions Reported by 28 Insiders of Elevance Health, Inc.

Symbol: ELV on NYSE
Location: Indianapolis, IN

Key facts

ELV - Elevance Health, Inc. has 28 insiders with reported activity on this page.
Net insider value flow over the last year: +$2,147,780.
Recent transaction rows are available for direct filing-level review.

Change

Buy value: $3,683,051; sell value: $1,535,271.
Net share flow: +7,947.

Research use

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Net insider flow leans to buying over the last 12 months. Net value: +$2,147,780.

Buys

$3,683,051

Shares: 12,700

Insiders: 3

Sells

$1,535,271

Shares: 4,753

Insiders: 3

Net

+$2,147,780

Shares: +7,947

Insiders: 0

Window (months)	Buy shares	Sell shares	Buy $	Sell $	Net $
0-3	3,000	4,753	$869,520	$1,535,271	-$665,751
3-6	0	0	$0	$0	$0
6-9	0	0	$0	$0	$0
9-12	9,700	0	$2,813,531	$0	+$2,813,531

Elevance Health, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Valuation	Report Date
Gail Boudreaux	President and CEO, Director	$55,914,957	+$2,438,951	+4.6%	Mixed	02 Mar 2026
John E. Gallina	EVP & Chief Financial Officer	$30,619,225			Mixed	01 Mar 2023
Gloria M. Mccarthy	EVP & Chief Administrative Off	$24,714,003			Mixed	24 Mar 2023
Julie A. Hill	Director	$14,997,534			Mixed	20 May 2021
Felicia F. Norwood	EVP &Chief Health Benefits Ofr	$12,826,249			Mixed	02 Mar 2026
Mark Kaye	Evp & Cfo	$10,580,219			Mixed	02 Mar 2026
Peter D. Haytaian	EVP & Pres Carelon & CarelonRx	$8,990,065			Mixed	02 Mar 2026
Prakash R. Patel	EVP & President, DBG	$8,278,843			Mixed	04 Sep 2021
Leah Stark	Evp & Chro	$5,959,517			Mixed	30 Dec 2021
Blair Williams Todt	Evp, Clo & Cao	$5,807,854			Mixed	01 Mar 2024
Elizabeth E. Tallett	Director	$5,481,810			Mixed	15 May 2024
Ratnakar Lavu	EVP & Chief Digital Info Ofr	$5,333,207			Mixed	02 Mar 2026
R. Kerry Clark	Director	$3,987,586			Mixed	14 May 2025
Lewis Hay III	Director	$3,533,492			Median	13 May 2026
Charles Morgan Kendrick Jr.	EVP & President, Commercial	$3,359,491	-$910,604	-21%	Filing P/S	06 Mar 2026
Robert L. Dixon Jr.	Director	$3,186,583			Median	13 May 2026
Ramiro G. Peru	Director	$2,900,567			Median	13 May 2026
Erin M. Wessling	EVP & Chief Legal Officer	$2,502,964			Mixed	02 Mar 2026
Jeffrey D. Alter	EVP, IngenioRx & Anthem Health	$2,453,862			Mixed	01 Oct 2021
Ryan R. Craig	EVP & Chief HR Officer	$2,204,088			Mixed	02 Mar 2026
Ryan M. Schneider	Director	$2,096,968			Median	13 May 2026
Ronald W. Penczek	CAO & Controller	$1,656,461	-$617,192	-27%	Filing P/S	19 May 2026
Antonio F. Neri	Director	$1,606,612			Median	13 May 2026
Jallal Bahija	Director	$1,566,505			Median	13 May 2026
Steven H. Collis	Director	$1,230,135	+$869,520	+241%	Median	13 May 2026
Susan D. DeVore	Director	$1,190,028	+$374,580	+46%	Median	13 May 2026
D. Strable Soethout	Director	$646,684			Median	13 May 2026
Amy W. Schulman	Director	$228,637	-$7,475	-3.2%	Median	13 May 2026

Top shareholders of Elevance Health, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock, Inc.	13D/G 13F	Company	7.8%	17,694,658	$7,319,395,282	$0	31 Mar 2025	13D/G 13F
VANGUARD CAPITAL MANAGEMENT LLC	13D/G 13F	Vanguard Capital Management · Company	7.1%	16,601,224	$4,860,008,326	$0	31 Mar 2026	13D/G 13F
Lewis Hay III	3/4/5	Director	0.01%	12,070	$3,533,492	—	13 May 2026	3/4/5
Robert L. Dixon Jr.	3/4/5	Director	0%	10,885	$3,186,583	—	13 May 2026	3/4/5
Ramiro G. Peru	3/4/5	Director	0%	9,908	$2,900,567	—	13 May 2026	3/4/5
R. Kerry Clark	3/4/5	Director	0%	9,640	$3,987,586	—	14 May 2025	3/4/5
Ryan M. Schneider	3/4/5	Director	0%	7,163	$2,096,968	—	13 May 2026	3/4/5
Antonio F. Neri	3/4/5	Director	0%	5,488	$1,606,612	—	13 May 2026	3/4/5
Jallal Bahija	3/4/5	Director	0%	5,351	$1,566,505	—	13 May 2026	3/4/5
Steven H. Collis	3/4/5	Director	0%	4,202	$1,230,135	+$869,520	13 May 2026	3/4/5
Ronald W. Penczek	3/4/5	CAO & Controller	0%	4,109	$1,656,461	-$617,192	19 May 2026	3/4/5
Susan D. DeVore	3/4/5	Director	0%	4,065	$1,190,028	+$374,580	13 May 2026	3/4/5
D. Strable Soethout	3/4/5	Director	0%	2,209	$646,684	—	13 May 2026	3/4/5
Amy W. Schulman	3/4/5	Director	0%	781	$228,637	-$7,475	13 May 2026	3/4/5
STATE STREET CORP	13F	Company	4.4%	10,288,696	$3,012,015,754	—	31 Mar 2026	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.5%	8,228,537	$2,408,904,208	—	31 Mar 2026	13F
VANGUARD PORTFOLIO MANAGEMENT LLC	13F	Company	2.7%	6,356,077	$1,860,741,542	—	31 Mar 2026	13F
Sanders Capital, LLC	13F	Company	2.5%	5,894,303	$1,725,557,203	—	31 Mar 2026	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	2.2%	5,192,707	$1,514,418,941	—	31 Mar 2026	13F
Artisan Partners Limited Partnership	13F	Company	2.2%	5,127,175	$1,500,980,481	—	31 Mar 2026	13F
Invesco Ltd.	13F	Company	2.1%	4,817,410	$1,410,296,925	—	31 Mar 2026	13F
HARRIS ASSOCIATES L P	13F	Company	2.1%	4,796,526	$1,404,182,987	—	31 Mar 2026	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2%	4,746,585	$1,389,564,000	—	31 Mar 2026	13F
First Eagle Investment Management, LLC	13F	Company	1.8%	4,132,291	$1,209,728,290	—	31 Mar 2026	13F
Bank of New York Mellon Corp	13F	Company	1.2%	2,845,280	$832,955,787	—	31 Mar 2026	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.2%	2,718,766	$795,918,735	—	31 Mar 2026	13F
Amundi	13F	Individual	1.2%	2,693,664	$788,570,137	—	31 Mar 2026	13F
MORGAN STANLEY	13F	Company	1.1%	2,629,104	$769,671,048	—	31 Mar 2026	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	1.1%	2,518,615	$737,324,542	—	31 Mar 2026	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.96%	2,236,129	$657,257,784	—	31 Mar 2026	13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC	13F	Company	0.94%	2,191,563	$641,580,068	—	31 Mar 2026	13F
NORTHERN TRUST CORP	13F	Company	0.93%	2,158,025	$631,761,818	—	31 Mar 2026	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.89%	2,078,364	$608,441,020	—	31 Mar 2026	13F
FMR LLC	13F	Company	0.85%	1,975,719	$578,391,678	—	31 Mar 2026	13F
Nuveen, LLC	13F	Company	0.84%	1,960,705	$573,996,475	—	31 Mar 2026	13F
Grantham, Mayo, Van Otterloo & Co. LLC	13F	Company	0.83%	1,938,276	$564,333,341	—	31 Mar 2026	13F
Legal & General Group Plc	13F	Company	0.81%	1,882,311	$551,046,553	—	31 Mar 2026	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.76%	1,770,495	$518,312,411	—	31 Mar 2026	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.71%	1,645,787	$481,682,553	—	31 Mar 2026	13F
CITADEL ADVISORS LLC	13F	Company	0.67%	1,562,219	$457,339,612	—	31 Mar 2026	13F
EAGLE CAPITAL MANAGEMENT LLC	13F	Company	0.67%	1,548,610	$453,355,469	—	31 Mar 2026	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.63%	1,476,183	$432,152,748	—	31 Mar 2026	13F
Ruane, Cunniff & Goldfarb L.P.	13F	Company	0.6%	1,387,968	$406,327,632	—	31 Mar 2026	13F
BAUPOST GROUP LLC/MA	13F	Company	0.55%	1,275,154	$373,301,000	—	31 Mar 2026	13F
VANGUARD FIDUCIARY TRUST CO	13F	Company	0.53%	1,242,444	$363,725,481	—	31 Mar 2026	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.53%	1,225,800	$358,852,950	—	31 Mar 2026	13F
BAILLIE GIFFORD & CO	13F	Company	0.5%	1,172,808	$343,339,542	—	31 Mar 2026	13F
Brave Warrior Advisors, LLC	13F	Company	0.48%	1,122,308	$328,555,667	—	31 Mar 2026	13F
JPMORGAN CHASE & CO	13F	Company	0.46%	1,069,955	$304,712,613	—	31 Mar 2026	13F
Capital International Investors	13F	Company	0.45%	1,050,861	$307,639,072	—	31 Mar 2026	13F

Recent Insider Transactions by Companies or Individuals for Elevance Health, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
Ronald W. Penczek	ELV	Common Stock	Sale	-27.2%	$617,192	$403.13	-1,531	4,109	19 May 2026	Direct
Ronald W. Penczek	ELV	Common Stock	Options Exercise	37.3%			1,531	5,640	19 May 2026	Direct
Ronald W. Penczek	ELV	Employee Stock Option (Right to Buy)	Options Exercise	-100%			-1,531	0	19 May 2026	Direct
D. Strable Soethout	ELV	Common Stock	Award	34.2%			563	2,209	13 May 2026	Direct
Amy W. Schulman	ELV	Common Stock	Award	258.3%			563	781	13 May 2026	Direct
Ryan M. Schneider	ELV	Common Stock	Award	8.53%			563	7,163	13 May 2026	Direct
Ramiro G. Peru	ELV	Common Stock	Award	6.02%			563	9,908	13 May 2026	Direct
Antonio F. Neri	ELV	Common Stock	Award	11.4%			563	5,488	13 May 2026	Direct
Bahija Jallal	ELV	Common Stock	Award	11.8%			563	5,351	13 May 2026	Direct
Lewis Hay III	ELV	Common Stock	Award	4.89%			563	12,070	13 May 2026	Direct
Robert L. Dixon Jr.	ELV	Common Stock	Award	5.45%			563	10,885	13 May 2026	Direct
Susan D. DeVore	ELV	Common Stock	Award	16.1%			563	4,065	13 May 2026	Direct
Steven H. Collis	ELV	Common Stock	Award	15.5%			563	4,202	13 May 2026	Direct
Amy W. Schulman	ELV	Common Stock	Sale	-10.7%	$7,475	$287.50	-26	218	12 Mar 2026	Direct
Charles Morgan Kendrick Jr.	ELV	Common Stock	Sale	-21.3%	$910,604	$284.92	-3,196	11,791	06 Mar 2026	Direct
Steven H. Collis	ELV	Common Stock	Purchase	469.5%	$869,520	$289.84	3,000	3,639	05 Mar 2026	Direct
Ronald W. Penczek	ELV	Common Stock	Tax liability	-0.89%			-37	4,099	03 Mar 2026	Direct
Erin M. Wessling	ELV	Common Stock	Tax liability	-5.22%			-417	7,579	03 Mar 2026	Direct
Ryan R. Craig	ELV	Common Stock	Tax liability	-4.43%			-309	6,674	03 Mar 2026	Direct
Felicia F. Norwood	ELV	Common Stock	Tax liability	-1.26%			-496	38,838	03 Mar 2026	Direct
Ratnakar Lavu	ELV	Common Stock	Tax liability	-1.36%			-222	16,149	03 Mar 2026	Direct
Charles Morgan Kendrick Jr.	ELV	Common Stock	Tax liability	-3.02%			-467	14,987	03 Mar 2026	Direct
Peter D. Haytaian	ELV	Common Stock	Tax liability	-1.61%			-446	27,222	03 Mar 2026	Direct
Mark Kaye	ELV	Common Stock	Tax liability	-1.09%			-353	32,037	03 Mar 2026	Direct
Gail Boudreaux	ELV	Common Stock	Tax liability	-1.02%			-1,736	169,251	03 Mar 2026	Direct
Ronald W. Penczek	ELV	Common Stock	Award	137.3%			2,393	4,136	02 Mar 2026	Direct
Ronald W. Penczek	ELV	Common Stock	Tax liability	-6.99%			-131	1,743	02 Mar 2026	Direct
Ronald W. Penczek	ELV	Employee Stock Option (Right to Buy)	Award				1,677	1,677	02 Mar 2026	Direct
Erin M. Wessling	ELV	Common Stock	Award	59.3%			2,976	7,996	02 Mar 2026	Direct
Erin M. Wessling	ELV	Employee Stock Option (Right to Buy)	Award				11,754	11,754	02 Mar 2026	Direct
Ryan R. Craig	ELV	Common Stock	Award	74.3%			2,976	6,983	02 Mar 2026	Direct
Ryan R. Craig	ELV	Common Stock	Tax liability	-0.62%			-25	4,007	02 Mar 2026	Direct
Ryan R. Craig	ELV	Employee Stock Option (Right to Buy)	Award				11,754	11,754	02 Mar 2026	Direct
Felicia F. Norwood	ELV	Common Stock	Award	28.9%			8,816	39,334	02 Mar 2026	Direct
Felicia F. Norwood	ELV	Common Stock	Tax liability	-4.45%			-1,421	30,518	02 Mar 2026	Direct
Felicia F. Norwood	ELV	Employee Stock Option (Right to Buy)	Award				23,512	23,512	02 Mar 2026	Direct
Ratnakar Lavu	ELV	Common Stock	Award	266.4%			11,903	16,371	02 Mar 2026	Direct
Ratnakar Lavu	ELV	Common Stock	Tax liability	-6.59%			-315	4,468	02 Mar 2026	Direct
Ratnakar Lavu	ELV	Employee Stock Option (Right to Buy)	Award				20,152	20,152	02 Mar 2026	Direct
Charles Morgan Kendrick Jr.	ELV	Common Stock	Award	73.5%			6,549	15,454	02 Mar 2026	Direct
Charles Morgan Kendrick Jr.	ELV	Common Stock	Tax liability	-12%			-1,211	8,905	02 Mar 2026	Direct
Charles Morgan Kendrick Jr.	ELV	Employee Stock Option (Right to Buy)	Award				15,870	15,870	02 Mar 2026	Direct
Peter D. Haytaian	ELV	Common Stock	Award	11.6%			2,865	27,668	02 Mar 2026	Direct
Peter D. Haytaian	ELV	Common Stock	Tax liability	-4.62%			-1,201	24,803	02 Mar 2026	Direct
Mark Kaye	ELV	Common Stock	Award	104.9%			16,579	32,390	02 Mar 2026	Direct
Mark Kaye	ELV	Common Stock	Tax liability	-1.69%			-271	15,811	02 Mar 2026	Direct
Mark Kaye	ELV	Employee Stock Option (Right to Buy)	Award				25,188	25,188	02 Mar 2026	Direct
Gail Boudreaux	ELV	Common Stock	Award	18.5%			26,680	170,987	02 Mar 2026	Direct
Gail Boudreaux	ELV	Common Stock	Tax liability	-4.45%			-6,713	144,307	02 Mar 2026	Direct
Gail Boudreaux	ELV	Employee Stock Option (Right to Buy)	Award				63,818	63,818	02 Mar 2026	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.